NCT07648095
Lacrifill for Ocular Surface Optimization in Cataract Surgery
Not Yet Recruiting
Not specifiedAges 40+ObservationalThe Eye Institute of West FloridaInvestigator-initiated
~65 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Lacrifill Canalicular Filler
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean absolute error (MAE)
Measured over 1 month postoperatively
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Neel Desai, MD · PRINCIPAL_INVESTIGATOR · The Eye Institute of West Florida
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age \>= 40 years
Diagnosed dry eye (OSDI \>= 13, TBUT \< 10 sec, or Oxford staining \>= Grade 2)
No recent ocular surgeries (\<6 months)
No significant changes in DED regimen within last 1 month
Exclusion
Previous punctal plugs or canalicular cautery
Active ocular inflammation or corneal pathology unrelated to DED
What this trial measures
- Mean absolute error (MAE)1 month postoperatively
Difference in mean spherical equivalent Mean Absolute Error (MAE) between actual postoperative manifest refraction spherical equivalent and back-calculated equivalent based on baseline biometry.